Advertisement
Departments | Specialty Focus | Non-Clinical Topics | News | Special Issues | e-Newsletter | Education | Archive | Site Search

Department of Veterans Affairs (VA)

Battlefield Lessons Save Lives, Limbs after Boston Marathon Explosions

SAN ANTONIO, TX - Ten years ago, many of the survivors of the Boston Marathon bombing with major lower body injuries would likely have spent the rest of their lives in a wheelchair. A new - and far more positive - set of expectations have been established, however, because of 12 years of experience with improvised explosive devices (IEDs) gained in Iraq and Afghanistan.

VA Will Introduce Productivity Models for Five MD Specialties This Year

Currently in Place for Radiology, Ophthalmology
WASHINGTON - Under pressure to develop an accurate method of assessing physician output and determining appropriate staffing levels at medical facilities, the VA has agreed to establish productivity models for five additional specialties by the end of this fiscal year.

pencil_white.jpgOpinion poll:
Does VA have an appropriate number of specialty physicians to meet patient-care needs? Please click here to participate in this month's U.S. Medicine readership poll.

VA's Overuse of GERD Treatment Under Scrutiny

PPIs Used Too Long
CHICAGO - How VA patients are treated, or potentially overtreated, for gastroesophageal reflux disease (GERD) is coming under greater scrutiny.

Lawmakers Seek to Extend Date for Camp Lejeune Healthcare Claims

New Research Indicates Water Contamination Began in 1953
WASHINGTON - Legislation signed into law in August was applauded for offering medical care through VA for veterans and family members exposed to contaminated drinking water at Camp Lejeune, NC.

First-in-Class Diabetes Drug Offers New Treatment Options for VA Patients

SAN DIEGO - The Food and Drug Administration’s (FDA) recent approval of canagliflozin might soon offer new treatment options for the more than one million VA patients with diabetes.

Diclegis Is Only Drug Approved for Nausea, Vomiting in Pregnant Women

BLAINVILLE, QUEBEC - Diclegis (doxylamine succinate and pyridoxine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat pregnant women experiencing nausea and vomiting.

First Lymph Node Mapping Drug Approved in More than 30 Years

DUBLIN, OH - The U.S. Food and Drug Administration recently approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, the first new drug used for lymph node mapping to be approved in more than 30 years.

FDA Approves Tecfidera for Treatment of Relapsing MS

WESTON, MA - The U.S. Food and Drug Administration has approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).

VA Urged to Resolve Whistleblower Complaints About Jackson, MI, VAMC

JACKSON, MS - Despite assurances that problems have been addressed at the G.V. (“Sonny) Montgomery VA Medical Center here, veterans expressed their anger to VA leaders during a town hall meeting held at the facility last month.

Telephone Intervention Effect Varied by Race, Health Literacy

DURHAM, NC - Race and health literacy were factors in the effectiveness of a telephone-based osteoarthritis (OA) self-management support intervention, according to a new study.1

Advertisement